AfricInvest Fund II

AfricInvest Fund II is a private equity fund managed by AfricInvest Capital Partners, focusing on growth and expansion of small and medium-sized enterprises (SMEs) in Sub-Saharan Africa. The fund primarily targets well-established companies with developed brands, products, distribution channels, and strong customer bases in their local markets. Investments typically range from €2 million to €10 million.

The fund's strategy is to provide growth capital to SMEs across various sectors, including education, financial services, food and agriculture, health, infrastructure, manufacturing, and technology and telecoms. Geographically, AfricInvest Fund II concentrates on countries such as Burkina Faso, Cameroon, Côte d'Ivoire, Ghana, Kenya, Libya, Mauritius, Nigeria, Senegal, and Tunisia.

AfricInvest Fund II has a track record of successful investments, including its exit from Kiboko Holdings Limited in 2018. This exit followed Kiboko's sale of a controlling stake in its pharmaceutical subsidiary, AK Life Sciences, to a global private equity firm. The fund's approach emphasizes adding value to portfolio companies through strategic guidance, operational improvements, and facilitating access to additional capital for expansion.